Cat.#: ACPP-1168
| Despition | KCNJ5 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1123 | Recombinant Rat GFAP Protein (AC1123) | 25 µl | inquiry |
| ACPP-1589 | Human BASP1 Protein (AC1589) | 2 µg | inquiry |
| ACPP-1216 | PARD3 Blocking Peptide (AC1216) | 250 µg | inquiry |
| ACPP-1350 | Presenilin 2 Blocking Peptide (AC1350) | 250 µg | inquiry |
| ACPP-1070 | Human Neuron Specific Enolase (Active) (AC1070) | 100 µg | inquiry |
| ACPP-1472 | Human PAX8 Protein (AC1472) | 2 µg | inquiry |
| ACPP-1456 | Human HEXA Protein (AC1456) | 5 µg | inquiry |
| ACPP-1013 | Recombinant Human GPCR GPRC5B Protein (Fc Tag) (AC1013) | 50 µg | inquiry |
| ACPP-1253 | Pin1 Blocking Peptide (AC1253) | 250 µg | inquiry |
| ACPP-1316 | GPCR GPR7 Blocking Peptide (AC1316) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.